Zynex Inc (ZYXI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zynex Inc (ZYXI) has a cash flow conversion efficiency ratio of 0.152x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.31 Million) by net assets ($-41.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zynex Inc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Zynex Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ZYXI liabilities breakdown for a breakdown of total debt and financial obligations.
Zynex Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zynex Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tesoro Minerals Corp.
V:TES
|
-0.394x |
|
CVC Income & Growth Limited
LSE:CVCG
|
0.019x |
|
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS
IS:LINK
|
0.021x |
|
Millennium Food-Tech LP
TA:MIFT
|
N/A |
|
Flexituff Ventures International Limited
NSE:FLEXITUFF
|
0.988x |
|
Redstone Resources Ltd
AU:RDS
|
-0.017x |
|
Awilco Drilling PLC
OL:AWDR
|
0.616x |
|
Adeunis
PA:ALARF
|
-3.682x |
Annual Cash Flow Conversion Efficiency for Zynex Inc (2000–2024)
The table below shows the annual cash flow conversion efficiency of Zynex Inc from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Zynex Inc (ZYXI) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $35.71 Million | $12.72 Million | 0.356x | -7.45% |
| 2023-12-31 | $46.13 Million | $17.76 Million | 0.385x | +85.82% |
| 2022-12-31 | $66.36 Million | $13.75 Million | 0.207x | +120.37% |
| 2021-12-31 | $73.92 Million | $6.95 Million | 0.094x | +553.35% |
| 2020-12-31 | $56.85 Million | $818.00K | 0.014x | -95.51% |
| 2019-12-31 | $19.65 Million | $6.30 Million | 0.321x | -68.30% |
| 2018-12-31 | $9.30 Million | $9.41 Million | 1.012x | -39.95% |
| 2017-12-31 | $4.90 Million | $8.26 Million | 1.685x | +476.85% |
| 2016-12-31 | $-3.80 Million | $1.70 Million | -0.447x | -433.81% |
| 2015-12-31 | $-4.07 Million | $341.00K | -0.084x | +88.96% |
| 2014-12-31 | $-1.27 Million | $961.00K | -0.758x | -862.60% |
| 2013-12-31 | $4.85 Million | $-382.00K | -0.079x | -8.06% |
| 2012-12-31 | $12.05 Million | $-879.00K | -0.073x | -104.24% |
| 2011-12-31 | $10.14 Million | $-362.00K | -0.036x | +56.08% |
| 2010-12-31 | $8.18 Million | $-665.00K | -0.081x | -116.68% |
| 2009-12-31 | $7.49 Million | $3.65 Million | 0.487x | +425.29% |
| 2008-12-31 | $4.77 Million | $-715.16K | -0.150x | -172.56% |
| 2007-12-31 | $3.62 Million | $746.86K | 0.206x | +154.98% |
| 2006-12-31 | $1.29 Million | $-483.46K | -0.376x | +23.75% |
| 2005-12-31 | $440.77K | $-217.06K | -0.492x | +90.58% |
| 2004-12-31 | $202.89K | $-1.06 Million | -5.229x | -25607.87% |
| 2003-12-31 | $-461.11K | $-9.45K | 0.021x | -98.71% |
| 2000-12-31 | $-594.94K | $-945.18K | 1.589x | -- |
About Zynex Inc
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more